Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20852, USA.
Aging Cell. 2012 Feb;11(1):24-8. doi: 10.1111/j.1474-9726.2011.00755.x. Epub 2011 Nov 15.
The regulation of telomere length (TL) is a complex process, requiring the telomerase enzyme complex and numerous regulatory proteins. Epigenetic regulation may also be important in telomere maintenance. Specifically, methylation at subtelomeres is associated with changes in TL in vitro and in mouse models. Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by exceedingly short telomeres and mutations in telomere biology genes. To understand the interaction between methylation and TL in humans, we measured LINE-1, pericentromeric (NBL2), and subtelomeric (D4Z4) methylation in peripheral blood DNA derived from 40 patients with DC and 51 mutation-negative relatives. Pearson's correlation coefficient and linear regression models were used to evaluate the relationship between age-standardized lymphocyte TL measured by flow FISH and % DNA methylation. No differences in % subtelomeric, LINE-1, or pericentromeric methylation between patients with DC and relatives were noted except for an increase in % subtelomeric methylation in DC patients with a telomerase-complex mutation (TERC, TERT, DKC1, or TCAB1) (63.0% in DC vs. 61.8% in relatives, P = 0.03). Positive correlations between TL and DNA methylation at LINE-1 (r = 0.39, P = 0.01) and subtelomeric (r = 0.32, P = 0.05) sites were present in patients with DC. The positive correlation between TL and % LINE-1 methylation was restricted to TINF2 mutations. In contrast, statistically nonsignificant inverse correlations between TL and % LINE-1 (r = -0.17), subtelomeric (r = -0.20) were present in unaffected relatives. This study suggests an interaction between TL and both subtelomeric and LINE-1 methylation, which may be altered based on mutation status of telomere biology genes.
端粒长度(TL)的调节是一个复杂的过程,需要端粒酶复合物和许多调节蛋白。表观遗传调控在端粒维持中也可能很重要。具体而言,亚端粒的甲基化与体外和小鼠模型中 TL 的变化有关。先天性角化不良(DC)是一种遗传性骨髓衰竭综合征,其特征是端粒极其短和端粒生物学基因的突变。为了了解甲基化和人类 TL 之间的相互作用,我们测量了来自 40 名 DC 患者和 51 名突变阴性亲属的外周血 DNA 中的 LINE-1、着丝粒周围(NBL2)和亚端粒(D4Z4)甲基化。Pearson 相关系数和线性回归模型用于评估通过流式 FISH 测量的年龄标准化淋巴细胞 TL 与 %DNA 甲基化之间的关系。除了端粒酶复合物突变(TERC、TERT、DKC1 或 TCAB1)的 DC 患者中亚端粒甲基化增加(63.0%在 DC 中比 61.8%在亲属中,P=0.03)外,DC 患者和亲属之间的亚端粒、LINE-1 或着丝粒周围甲基化的%没有差异。在 DC 患者中,TL 与 LINE-1(r=0.39,P=0.01)和亚端粒(r=0.32,P=0.05)位点的 DNA 甲基化之间存在正相关。TL 与 %LINE-1 甲基化之间的正相关仅限于 TINF2 突变。相比之下,未受影响的亲属中 TL 与 %LINE-1(r=-0.17)和亚端粒(r=-0.20)之间存在统计学上无显著的负相关。这项研究表明 TL 与亚端粒和 LINE-1 甲基化之间存在相互作用,这种相互作用可能基于端粒生物学基因的突变状态而改变。